Moneycontrol PRO
HomeNewsApproval

Approval

Jump to
  • Bengaluru Metro's Rs 28,405-crore Hebbal-Sarjapur corridor gets Karnataka govt approval

    With the state government approving the 37-km Hebbal-Sarjapur corridor, BMRCL can now commence the land acquisition process. However, final approval from the Union government is required to begin construction.

  • MC Exclusive I Union Cabinet may consider Rs 14,425-crore additional funding for Polavaram irrigation project on October 9

    The newly elected Andhra Pradesh government was asked to submit a report on inflation-adjusted costs to the Union Finance Ministry in June 2024, for Central assistance to resume development of the proposed state capital of Amaravati and the Polavaram irrigation project.

  • Lupin receives US FDA approval for generic anti-fungal drug

    The product will be manufactured at Lupin’s Pithampur facility in India. Fluconazole tablets USP had estimated annual sales of $43 million in the US according to IQVIA MAT data in July 2023

  • GMR Smart Electricity Distribution bags Rs 5,123.37 crore UP contract

    GSEDPL will install, integrate and maintain 50.17 lakh smart meters in Varanasi, Azamgarh, Prayagraj and Mirzapur zones of Uttar Pradesh

  • Lupin gets US FDA approval for Bromfenac ophthalmic solution

    This generic version, known as Bromfenac Ophthalmic Solution 0.09%, will be manufactured at Lupin's facility at Pithampur

  • World’s first flying car for Rs 2.5 crore gets nod from US government

    The flying car is 100% electric, can be driven on roads, has vertical take-off and landing capabilities and can carry one or two occupants.

  • Zydus Lifesciences gets final USFDA approval to mfg, market generic version of Varenicline tablets

    The approval by the US Food and Drug Administration (USFDA) is for Varenicline tablets of strengths 0.5 mg and 1 mg.

  • Lupin receives USFDA approval for generic medicine

    The approval granted by the US Food and Drug Administration (US FDA) is for the abbreviated new drug application for Brexpiprazole tablets of strengths 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, the company said in a regulatory filing.

  • Zydus Lifesciences gets final USFDA approval for drug to treat high uric acid

    The approval granted by the US Food and Drug Administration (USFDA) to market Febuxostat tablets is for strengths of 40 mg and 80 mg.

  • Airbus receives regulatory approval for C295 India aircraft programme

    In September last year, India sealed a nearly Rs 21,000 crore deal with Airbus Defence and Space to procure 56 C295 transport aircraft to replace the ageing Avro-748 planes of the IAF

  • Cerberus, Oaktree and JC Flowers shortlisted for Yes Bank’s planned ARC

    Cerberus is said to be the frontrunner. Process advisor EY had indicated that applicants ready to infuse Rs 1,500-2,000 crore would be given preference

  • Final approval for changed GST rules to be done in next meeting

  • Centre allows TN to increase job days under MGNREGA scheme

    The Centre has given its approval for increasing the number of days of employment given to rural household workers under the Mahatma Gandhi National Rural Employment Guarantee Act in Tamil Nadu from the existing 100 days to 150 days benefitting 1.23 crore workers.

  • Zydus Cadila gets USFDA nod for chemotherapy drug

    Drug firm Zydus Cadila today said it has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in the American market.

  • Lupin gets USFDA nod to market skin ointment

    Drug major Lupin has received approval from the US health regulator to market generic Desoximetasone ointment, used to treat inflammation and itching, in the American market.

  • Cabinet gives in-principle nod to PSU strategic stake sale

    The Union Cabinet today gave in-principle approval to NITI Aayog's proposal for strategic sale of state-owned firms and entrusted DIPAM with the task of finalising the PSUs in which management control can be transferred to private players.

  • PGCIL may raise Rs 4,000 cr through bonds by September

    State utility Power Grid Corporation India (PGCIL) plans to raise up to Rs 4,000 crore in its third round of fund raising through domestic bonds by September to meet its working capital expenditure.

  • 'Realty Bill has no provision for expediting approvals'

    Even as the Real Estate Bill aims at bringing in transparency and accountability for delay in projects' execution, it hasn't made any distinction in situations where projects are delayed because of approvals, says ICRA.

  • Mindtree shareholders approve bonus shares, top brass rejig

    According to the statement, the shareholders also passed ordinary resolution to appoint Krishnakumar Natarajan as Executive Chairman and Rostow Ravanan as CEO & Managing Director, with majority votes.

  • Aurobindo Pharma gets USFDA nod for oral contraceptives

    Drug firm Aurobindo Pharma has received final approval from the US health regulator to manufacture and market its oral contraceptive, Levonorgestrel tablets.

  • JetLite to merge with parent carrier Jet Airways

    The Naresh Goyal-promoted Jet Airways today said its board has approved merger of the low-cost subsidiary JetLite with the parent airline.

  • Govt's nod to 6 new SEZ proposals; rejection of 3 approved

    The decision was taken by the Board of Approval (BoA) for SEZ, chaired by Commerce Secretary Rita Teaotia, a Commerce Ministry official said. The proposals which got the approval include those of HCL IT City Lucknow, Loma IT Park Developer and North Mumbai International Commodity Township.

  • 3 SEZs seek govt nod to surrender zones, 17 buy time

    Furthermore, 17 special economic zone (SEZ) developers, including Navi Mumbai SEZ Pvt, Shantha Biotechnics and Electronics Corporation of Tamil Nadu, have sought time from the government to implement their respective projects, which are at different stages of implementation.

  • Govt cancels 22 SEZs, give time to 27 to execute projs

    The decision was taken in the meeting of the Board of Approval (BoA) headed by Commerce Secretary Rajeev Kher on May 19. "The Board examined the 22 cases of the agenda for cancellation of formal approval/notification.

  • Cairn India-Vedanta deal: Cairn Energy still on sidelines

    Cairn Energy Plc has told CNBC-TV18 there is no change in its stance to fight India's draft assessment of USD 1.6 billion and confirmed it is still banned from selling shares in Cairn India.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347